Browse studies

Find your next paid study

27,295 recruiting studies available now

A Phase III, Multisite, Randomized, Double-Blind Trial of BNT327 in Combination With Chemotherapy Versus Placebo With Chemotherapy in Patients With Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC Determined Ineligible for PD(L)1 Therapy Based on PD-L1 Negative Disease

This is a Phase III trial where participants will be randomized to two treatment groups, which means participants will be assigned by equal chance to a treatme…

Breast Neoplasms

Estimated

~$50 – $2,250

Actual pay is set by the research site.

BioNTech SENCT07173751

Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Background: Researchers seek ways to study people s medical problems in order to teach and further general knowledge. The ability to assess and treat people w…

Wide Spectrum of DiseasesHematologic Diseases

Estimated

~$10 – $675

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT04450927

Phase 2

A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial

Major depressive disorder (MDD) is a significant public health problem and leading cause of worldwide disability. Treatment resistance is common in MDD, howeve…

Treatment Resistant DepressionTreatment Resistant Depression (TRD)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

NeuroRx, Inc.NCT07227103

Phase 2

A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety

The goal of this study is to learn how psychedelics may help symptoms of depression and anxiety. Participants with major depressive disorder experiencing sympt…

DepressionAnxietyMajor Depressive Disorder

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Ohio State UniversityNCT06820723

Phase 1

Phase 1/2 Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM

Background: Warts, hypogammaglobulinemia, infections and myelokathexis syndrome (WHIMs) is a rare disorder that affects the immune system. People with WHIMs c…

WHIMWartsHypogammaglobulinemia+2 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT07775313

Phase 3

An Open-Label Extension Study to Assess the Safety and Efficacy of Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

The purpose of this study is to obtain safety, efficacy, and pharmacodynamic data on the use of vutrisiran in patients with ATTR amyloidosis with cardiomyopath…

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Alnylam PharmaceuticalsNCT06679946

Observational

Nonoperative vs. Surgical Release for Acute-to-Subacute Lateral Epicondylitis: A Prospective Randomized Controlled Trial

Tennis elbow is a condition that causes pain on the outside of the elbow, typically caused by motions involving straightening of the arm. The goal of this clin…

Lateral Epicondylitis

Estimated

~$10 – $750

Actual pay is set by the research site.

University of PittsburghNCT07885280

Observational

Temporal Nature of Cognitive and Visuospatial Brain Domain Changes During Long-Duration Low-Earth Orbit Missions (Spatial Cognition)

This study investigates the effects of extended-duration spaceflight (12-month International Space Station missions) on general cognitive performance (measured…

Brain StructureCognitive Performance

Estimated

~$10 – $750

Actual pay is set by the research site.

University of PennsylvaniaNCT04856410

Phase 3

A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, ACTIVE- AND PLACEBO-CONTROLLED PHASE 3 MONOTHERAPY STUDY WITH MAINTENANCE PERIOD TO INVESTIGATE THE EFFICACY AND SAFETY OF TILREKIMIG IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

The purpose of this study is to find out how well tilrekimig works, how safe it is, and how it affects the body in adults and adolescents with moderate to seve…

Atopic Dermatitis

Estimated

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT07783425

Phase 1

Phase 1/1b First-in-human Study of Autologous Chimeric Engulfment Receptor T-Cell CER-1236 in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Myelofibrosis (CertainT-1)

This is a ﬁrst in human, multi center, open label, phase 1/1b study to evaluate the safety and preliminary efﬁcacy of CER-1236 in patients with relapsed/refrac…

AMLAcute Myeloid LeukemiaRefractory Acute Myeloid Leukemia

Estimated

~$150 – $4,200

Actual pay is set by the research site.

CERo Therapeutics Holdings, Inc.NCT06834282

Observational

Empower EI: Comparing Early Intervention Approaches to Improve Communication in Toddlers With Developmental Delays

This study is testing three ways to deliver Early Intervention (EI) services for toddlers with developmental disabilities (DD). Children enrolled in EI speech…

Developmental Delays

Estimated

~$10 – $750

Actual pay is set by the research site.

Northwestern UniversityNCT07227974

Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques

Background: Tics are involuntary movements and vocalizations. Some tics are organic: They are related to diagnosed disorders. Sometimes tics have other causes…

TicsFunctional Tics

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Neurological Disorders and Stroke (NINDS)NCT07137442